Everest Organics Q1 FY27 Results (BSE: 524790)
Signal: Revenue declined
The read
The key inflection is a 10.0% YoY revenue contraction in the API business, with EBITDA down a narrower 4.8% to ₹475.00 lakh but PAT down 21.3% to ₹111.34 lakh; the earnings quality is weaker because other income represented 27.5% of PBT.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹48.43 Cr | -10.0% | N/A |
| EBIT | ₹3.16 Cr | -8.9% | |
| Net profit | ₹1.11 Cr | -21.3% | |
| EPS | ₹1.15 | -20.7% | |
| EBIT margin | 9.8% |
P&L walk
Standalone revenue fell to ₹4,843.00 lakh, down 10.0% YoY, while EBITDA declined 4.8% to ₹475.00 lakh and PAT declined faster by 21.3% to ₹111.34 lakh; other income contributed 27.5% of PBT, making the bottom line less representative of operating performance.
Key positives
- EBITDA declined 4.8% YoY to ₹475.00 lakh, outperforming the 10.0% YoY revenue decline and indicating partial cost absorption despite lower sales.
- Export turnover contributed ₹1,078.23 lakh of Q1 revenue, providing a material non-domestic channel within the API business.
Key concerns
- Revenue declined 10.0% YoY to ₹4,843.00 lakh, reversing the growth trajectory implied by the company's prior reported scale.
- PAT declined 21.3% YoY to ₹111.34 lakh, materially faster than EBITDA's 4.8% decline.
- Other income was 27.5% of PBT, so the ₹111.34 lakh PAT includes a material non-operating contribution and is less reflective of recurring operating earnings.
Earnings quality: includes non-operating other income
Research and educational content only. Not investment advice.